222 related articles for article (PubMed ID: 30345261)
1. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.
Adejumo AC; Adegbala OM; Adejumo KL; Bukong TN
Can J Gastroenterol Hepatol; 2018; 2018():9430953. PubMed ID: 30345261
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.
Adejumo AC; Ajayi TO; Adegbala OM; Adejumo KL; Alliu S; Akinjero AM; Onyeakusi NE; Ojelabi O; Bukong TN
Liver Int; 2018 Aug; 38(8):1475-1486. PubMed ID: 29341392
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
5. Reduced Prevalence of Alcoholic Gastritis in Hospitalized Individuals Who Consume Cannabis.
Adejumo AC; Li J; Akanbi O; Adejumo KL; Bukong TN
Alcohol Clin Exp Res; 2019 Feb; 43(2):270-276. PubMed ID: 30536396
[TBL] [Abstract][Full Text] [Related]
6. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
[TBL] [Abstract][Full Text] [Related]
7. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
[TBL] [Abstract][Full Text] [Related]
8. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
Cholankeril G; Perumpail RB; Hu M; Skowron G; Younossi ZM; Ahmed A
Dig Dis Sci; 2016 Sep; 61(9):2505-15. PubMed ID: 27084385
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C
Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
[TBL] [Abstract][Full Text] [Related]
12. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.
Sagnelli E; Stroffolini T; Sagnelli C; Smedile A; Morisco F; Furlan C; Babudieri S; Brancaccio G; Coppola N; Gaeta GB; Almasio PL;
Dig Liver Dis; 2016 Sep; 48(9):1066-71. PubMed ID: 27291331
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
15. Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011.
Charilaou P; Agnihotri K; Garcia P; Badheka A; Frenia D; Yegneswaran B
Am J Med; 2017 Jun; 130(6):678-687.e7. PubMed ID: 28161344
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
17. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
[TBL] [Abstract][Full Text] [Related]
19. Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ; Weideman R; Crook T; Brown G
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):181-6. PubMed ID: 26566061
[TBL] [Abstract][Full Text] [Related]
20. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
